EUVIMEDEUVIMED entdecken
Open Access

Dual‐Switchable Nanoparticles Resolving the Safety‐Efficacy Paradox of Sonodynamic Immunotherapy for Hepatocellular Carcinoma

Xiujun Gao, Yao Wang, Mingyuan Wang, Boyi Zhang, Ying Wang, Ting Zhang, Yirui Liu, Ying Li, Luchen Chang iD, Shuyue Guo, Chunhong Hu iD, Xi Wei iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiujun Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nanoparticles, Immunotherapy. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Tianjin Key Medical Discipline Construction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical translation of sonodynamic therapy for hepatocellular carcinoma is limited by a safety‐efficacy paradox: sonosensitizer activation in healthy tissues poses risks, while tumor efficacy is constrained by hypoxia and redundant antioxidant defenses. To resolve this, dual‐switchable core‐shell nanoparticles were engineered. Under physiological conditions, a carboxymethyl chitosan shell and a peptide radical scavenger keep the nanoparticles inert, ensuring systemic safety. In the acidic tumor microenvironment, the shell disassembles, and ultrasound exposure triggers a coordinated therapeutic cascade. The linear dumbbell‑shaped piezoelectric core, barium titanate‑gold‑barium titanate heterojunction, generates oxygen, alleviating tumor hypoxia, and simultaneously produces oxyradicals, enabled by a record piezopotential of 4.12 V and its inherent direct water‑splitting capability. Two inhibitors are released to block the AMP‑activated protein kinase and nuclear factor erythroid two‐related factor 2 antioxidant pathways, disabling cellular defenses and amplifying oxidative damage. This integrated strategy induces ferroptosis, mitochondrial dysfunction, DNA damage, and immunogenic cell death, as validated by physicochemical characterization, multi‐omics, and in vivo studies. In subcutaneous tumor models, inhibition rates reached 98.7% in immunocompetent mice and 91.9% in T‑cell‑deficient mice, with excellent safety. This work establishes a therapeutic paradigm reconciling systemic safety with potency, offering a translatable strategy for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNanoparticlesImmunotherapyUltrasonic TherapyAnimalsHumansMiceCell Line, TumorTitaniumBarium CompoundsChitosanGoldTumor Microenvironment

Stichwörter der Autor:innen

bioinert‐to‐bioactive switchingdual‐switchable nanoparticleshepatocellular carcinomaimmunogenic cell deathsonodynamic therapy

Substanzen

TitaniumBarium CompoundsChitosanGoldbarium titanate(IV)

Autor:innen und Institutionen

  • School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
  • Department of Diagnostic and Therapeutic Ultrasonography, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin M…
  • The Third Surgical Department of Breast Cancer, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical Uni…

ORCID-Profile: Luchen Chang, Chunhong Hu, Xi Wei

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Tianjin Key Medical Discipline Construction
  • State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Medical University Cancer Institute & Hospital

Zitieren

APA

Gao, X., Wang, Y., Wang, M., Zhang, B., Wang, Y., Zhang, T., Liu, Y., Li, Y., Chang, L., Guo, S., Hu, C., & Wei, X. (2026). Dual‐Switchable Nanoparticles Resolving the Safety‐Efficacy Paradox of Sonodynamic Immunotherapy for Hepatocellular Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71562

Vancouver

Gao X, Wang Y, Wang M, Zhang B, Wang Y, Zhang T, et al. Dual‐Switchable Nanoparticles Resolving the Safety‐Efficacy Paradox of Sonodynamic Immunotherapy for Hepatocellular Carcinoma. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71562

BibTeX
@article{Gao2026,
  author = {Gao, Xiujun and Wang, Yao and Wang, Mingyuan and Zhang, Boyi and Wang, Ying and Zhang, Ting and Liu, Yirui and Li, Ying and Chang, Luchen and Guo, Shuyue and Hu, Chunhong and Wei, Xi},
  title = {Dual‐Switchable Nanoparticles Resolving the Safety‐Efficacy Paradox of Sonodynamic Immunotherapy for Hepatocellular Carcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71562}
}
Kostenlos starten →